Abstract 52: Impaired Ephrin A1/EphA2 Signaling Results in Defective Migration and Homing of Senescent Human Cardiac Stem Cells

2012 ◽  
Vol 111 (suppl_1) ◽  
Author(s):  
Ramaswamy Kannappan ◽  
Yingnan Bai ◽  
Sergio Signore ◽  
Maria Cimini ◽  
Joao Ferreira-Martins ◽  
...  

Aging is the major independent risk factor for chronic heart failure. Despite the presence of cardiac stem cells (CSCs), the old human heart undergoes progressive deterioration in ventricular performance, coupled with scattered foci of fibrosis and accumulation of poorly contracting myocytes. We raised the possibility that defects in the translocation of senescent human CSCs (hCSCs) to the sites of damage constitute a key determinant in the manifestation of the aging myopathy. We report that ephrin A1-EphA2 receptor signaling is a critical modulator of hCSC motility. Ephrin A1, a membrane-anchored protein, is expressed on the myocyte sarcolemma and acts as a ligand for the EphA2 receptor on neighboring hCSCs, facilitating their migration. Pre-treatment of young hCSCs with ephrin A1 resulted in enhanced movement of the transplanted cells to the necrotic tissue, with formation of new myocardium and improvement in cardiac function. Whether senescent hCSCs promote a comparable regenerative response remained to be established. Surprisingly, the expression of EphA2 did not differ in young and old hCSCs. With respect to young cells, senescent hCSCs showed a 2-fold increase in intracellular ROS levels. Oxidative stress led to post-translational modifications and functional alterations of the EphA2 receptor. Specifically, the ability of ephrin A1 to induce phosphorylation of the EphA2 receptor was markedly attenuated in senescent hCSCs, resulting in inadequate activation of Src family proteins. As a consequence, the phosphorylation and activity of caveolin-1, a substrate of Src kinases, was reduced. These molecular alterations led to impaired endocytosis of the ligand-receptor complex, a cellular process essential for ephrin A1-EphA2 signaling. Lack of endocytosis precluded rearrangement of the actin cytoskeleton and cell migration. Importantly, ephrin A1-stimulated senescent hCSCs delivered to infarcted rats accumulated in proximity of the site of injection and did not translocate to the ischemic area. Thus, oxidative stress interferes with EphA2 signaling in aging hCSCs, negatively affecting their migration. Restoration of the EphA2 function in old hCSCs may enhance their mobilization and improve cell targeting to the injured area.

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Andrew J Smith ◽  
Iolanda Aquila ◽  
Beverley J Henning ◽  
Mariangela Scalise ◽  
Bernardo Nadal-Ginard ◽  
...  

The identification of resident, endogenous cardiac stem cells (eCSCs) has re-shaped our understanding of cardiac cellular physiology, while offering a significant potential therapeutic avenue. The biology of these cells must be better understood to harness their potential benefits. We used an acute dose (s.c.; 5mgkg-1) of isoproterenol (ISO) to induce diffuse cardiac injury, with associated eCSC activation, in rats. As peak eCSC activation was at 24 hours post ISO-injury, c-kitpos eCSCs were isolated, characterised and their potential for growth and regenerative potential was assessed in vitro and in vivo, respectively. Activated eCSCs showed increased cell cycling activity (51+1% in S- or G2/M phases vs. 9+2% of quiescent), Ki67 expression (56+7% vs. 10+1%) and TERT expression (14-fold increase vs. quiescent). When directly harvested in culture, activated eCSCs showed augmented proliferation, clonogenicity and cardiosphere formation compared to quiescent eCSCs. Activated eCSCs showed increases in expression of numerous growth factors, particularly HGF, IGF-1, TGF-β, periostin, PDGF-AA and VEGF-A. Furthermore, significant alterations were found in the miRnome, notably increased miR-146b and -221, and decreased miR-192 and -351. ISO+5FU was administrated to mice to induce a model of chronic dilated cardiomyopathy, which is characterized by the ablation of eCSCs and the absence of cardiomyocyte replenishment. In these mice with chronic heart failure, freshly isolated quiescent eCSCs or activated eCSCs (2d post-ISO) were injected through the tail vein. 28 days after injection, activated but not quiescent eCSCs re-populated the resident CSC pool, promoted robust new cardiomyocyte formation and improved cardiac function when compared to saline-treated mice. Dual-labelling with BrdU and EdU at selected stages after ISO injury determined that activated eCSCs returned to a quiescent level by 10 weeks post-injury. In conclusion, CSCs rapidly switch from a quiescent to an activated state to match the myocardial needs for myocyte replacement after injury and then spontaneously go back to quiescence. Harnessing the molecules regulating this process may open up future novel approaches for effective myocardial regeneration.


2008 ◽  
Vol 105 (2) ◽  
pp. 612-623 ◽  
Author(s):  
T.J. Bartosh ◽  
Zhaohui Wang ◽  
Armando A. Rosales ◽  
S. Dan Dimitrijevich ◽  
Rouel S. Roque

2014 ◽  
Vol 115 (suppl_1) ◽  
Author(s):  
Victoria Florea ◽  
Sonia S Majid ◽  
Rosemeire M Kanashiro-Takeuchi ◽  
Norman L Block ◽  
Andrew V Schally ◽  
...  

Background: Our group has previously shown that growth hormone releasing hormone receptor agonists (GHRHR-A) improve cardiac performance in heart failure models and reverse remodeling. This effect was associated with an increase in the number of c-kit+ cardiac stem cells (CSCs), suggesting that this agonist might have an effect on these cells. Methods and Results: We investigated the expression of GHRH receptor (GHRHR) in CSCs of different species by flow cytometry analysis. GHRH-R is expressed in 96-98% of CSCs isolated from mouse, rat and porcine. Results were compared to GHRHR expression in HeLa and MCF7, and T47D cell lines, positive and negative controls, respectively. To determine if GHRHR activation can improve CSCs self-renewal, we tested the effect of agonists on porcine CSCs proliferation. The rate of cell division was increased 2-fold with JI38 (GHRHR-A) treatment (3.4 ± 0.7) vs. vehicle control (1.7 ± 0.2) (p<0.05). Pre-treatment of CSCs with the GHRHR antagonist MIA-602, showed a trend toward reversal of the JI38 agonistic effect on proliferation rate (2.2 ± 0.6). These studies were further extended to other GHRHR agonists. In addition to JI38, MR356 and MR409, both of which showed significant increase in CSCs proliferation relative to vehicle control, by 20 ± 5.7%, 37 ± 8.5% and 36 ± 12.2%, respectively (p<0.05). The protective effect of JI38 on porcine CSCs survival was determined under oxidative stress generated by hydrogen peroxide exposure. Pre-treatment of CSCs with JI38 prior to peroxide exposure significantly reduced cell death by 33 ± 2.2% (p<0.02). Similar effects were observed for MR356, which decreased cell death by 12 ± 8.6% (p<0.03). Furthermore, we found that the effect of GHRHR-A on CSCs proliferation was completely reversed by inhibitors of the ERK, PI3K and Akt pathways (p<0.05). Conclusion: These findings confirm for the first time the expression of GHRHR in CSCs. GHRHR-A promotes CSCs proliferation and enhance survival. GHRHR-A effects on CSCs proliferation are mediated through activation of ERK, PI3K and AKT pathways. Accordingly, activation of GHRHR signaling pathways represents a novel therapeutic approach to protect and stimulate endogenous CSC population, promoting cardiac repair.


2018 ◽  
Vol 2018 ◽  
pp. 1-21 ◽  
Author(s):  
Yan Wang ◽  
Ranzun Zhao ◽  
Debin Liu ◽  
Wenwen Deng ◽  
Guanxue Xu ◽  
...  

Cardiac stem cells (CSCs) have emerged as one of the most promising stem cells for cardiac protection. Recently, exosomes from bone marrow-derived mesenchymal stem cells (BMSCs) have been found to facilitate cell proliferation and survival by transporting various bioactive molecules, including microRNAs (miRs). In this study, we found that BMSC-derived exosomes (BMSC-exos) significantly decreased apoptosis rates and reactive oxygen species (ROS) production in CSCs after oxidative stress injury. Moreover, a stronger effect was induced by exosomes collected from BMSCs cultured under hypoxic conditions (Hypoxic-exos) than those collected from BMSCs cultured under normal conditions (Nor-exos). We also observed greater miR-214 enrichment in Hypoxic-exos than in Nor-exos. In addition, a miR-214 inhibitor or mimics added to modulate miR-214 levels in BMSC-exos revealed that exosomes from miR-214-depleted BMSCs partially reversed the effects of hypoxia-induced exosomes on oxidative damage in CSCs. These data further confirmed that miR-214 is the main effector molecule in BMSC-exos that protects CSCs from oxidative damage. miR-214 mimic and inhibitor transfection assays verified that CaMKII is a target gene of miR-214 in CSCs, with exosome-pretreated CSCs exhibiting increased miR-214 levels but decreased CaMKII levels. Therefore, the miR-214/CaMKII axis regulates oxidative stress-related injury in CSCs, such as apoptosis, calcium homeostasis disequilibrium, and excessive ROS accumulation. Collectively, these findings suggest that BMSCs release miR-214-containing exosomes to suppress oxidative stress injury in CSCs through CaMKII silencing.


2012 ◽  
Vol 26 (S1) ◽  
Author(s):  
Wasana K. Sumanasekera ◽  
David Tran ◽  
Gregg Rokosh ◽  
Thimira Sumanasekera ◽  
Hieu T. Tran

2017 ◽  
Vol 26 (24) ◽  
pp. 1771-1780 ◽  
Author(s):  
Ayeshah A. Rosdah ◽  
Simon T. Bond ◽  
Priyadharshini Sivakumaran ◽  
Ashfaqul Hoque ◽  
Jonathan S. Oakhill ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document